Phibro Animal Health Corporation (PAHC)

Net profit margin

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net income (ttm) US$ in thousands 48,264 31,792 19,317 17,406 2,431 13,177 14,814 20,750 32,606 28,608 36,255 46,510 49,188 58,788 53,260 48,596 54,364 42,864 44,204 43,297
Revenue (ttm) US$ in thousands 1,296,215 1,190,682 1,106,080 1,046,762 1,017,630 999,515 981,965 976,668 977,889 978,140 972,086 960,152 942,296 907,296 879,406 852,843 833,372 798,972 797,982 805,845
Net profit margin 3.72% 2.67% 1.75% 1.66% 0.24% 1.32% 1.51% 2.12% 3.33% 2.92% 3.73% 4.84% 5.22% 6.48% 6.06% 5.70% 6.52% 5.36% 5.54% 5.37%

June 30, 2025 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $48,264K ÷ $1,296,215K
= 3.72%

The analysis of Phibro Animal Health Corporation's net profit margin over the period from September 2020 to June 2025 reveals a pattern characterized by initial stability followed by a consistent decline, with recent periods showing signs of modest recovery.

During the latter half of 2020 and the early part of 2021, the net profit margin fluctuated within a narrow range, starting at approximately 5.37% in September 2020 and reaching a peak of around 6.52% in June 2021. This indicated a relatively stable and healthy profitability level in that interval.

Subsequently, from the second quarter of 2021 onward, there was a noticeable downward trend. The margin declined gradually from its peak, decreasing to approximately 4.84% by September 2022 and continuing to fall sharply to 3.73% in December 2022. The downward trajectory persisted into 2023, with the margin dropping further to 2.92% in March 2023 and then to 1.51% in December 2023.

In the first half of 2024, the margin experienced an additional decline, reaching a low of 0.24% in June 2024. However, from mid to late 2024 and into the first half of 2025, there were signs of recovery, with the margin increasing to 1.66% in September 2024, 1.75% in December 2024, and improving further to 2.67% in March 2025 and 3.72% in June 2025.

Overall, the net profit margin has shown a considerable compression from its earlier levels, indicative of declining profitability over the observed period, although recent data points suggest a potential stabilization or minor recovery phase beginning in late 2024 and into 2025.